297 related articles for article (PubMed ID: 37823192)
21. Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys.
Le Hir M; Hegyi I; Cueni-Loffing D; Loffing J; Kaissling B
Histochem Cell Biol; 2005 Jun; 123(4-5):335-46. PubMed ID: 15856273
[TBL] [Abstract][Full Text] [Related]
22. Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition.
Zhou R; Liao J; Cai D; Tian Q; Huang E; Lü T; Chen SY; Xie WB
FASEB J; 2021 Mar; 35(3):e21381. PubMed ID: 33617091
[TBL] [Abstract][Full Text] [Related]
23. An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction.
Ruetten H; Cole C; Wehber M; Wegner KA; Girardi NM; Peterson NT; Scharpf BR; Romero MF; Wood MW; Colopy SA; Bjorling DE; Vezina CM
PLoS One; 2020; 15(7):e0232564. PubMed ID: 32726309
[TBL] [Abstract][Full Text] [Related]
24. Myofibroblast transcriptome indicates SFRP2
Tabib T; Huang M; Morse N; Papazoglou A; Behera R; Jia M; Bulik M; Monier DE; Benos PV; Chen W; Domsic R; Lafyatis R
Nat Commun; 2021 Jul; 12(1):4384. PubMed ID: 34282151
[TBL] [Abstract][Full Text] [Related]
25. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.
Sun YB; Qu X; Caruana G; Li J
Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
[TBL] [Abstract][Full Text] [Related]
27. Myofibroblasts acquire retinoic acid-producing ability during fibroblast-to-myofibroblast transition following kidney injury.
Nakamura J; Sato Y; Kitai Y; Wajima S; Yamamoto S; Oguchi A; Yamada R; Kaneko K; Kondo M; Uchino E; Tsuchida J; Hirano K; Sharma K; Kohno K; Yanagita M
Kidney Int; 2019 Mar; 95(3):526-539. PubMed ID: 30661714
[TBL] [Abstract][Full Text] [Related]
28. Targeting Bone Marrow-Derived Fibroblasts for Renal Fibrosis.
An C; Jia L; Wen J; Wang Y
Adv Exp Med Biol; 2019; 1165():305-322. PubMed ID: 31399971
[TBL] [Abstract][Full Text] [Related]
29. Significance of α-SMA in myofibroblasts emerging in renal tubulointerstitial fibrosis.
Ina K; Kitamura H; Tatsukawa S; Fujikura Y
Histol Histopathol; 2011 Jul; 26(7):855-66. PubMed ID: 21630215
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
Ping Q; Wang C; Cheng X; Zhong Y; Yan R; Yang M; Shi Y; Li X; Li X; Huang W; Wang L; Bi X; Hu L; Yang Y; Wang Y; Gong R; Tan J; Li R; Li H; Li J; Wang W; Li R
J Transl Med; 2023 Jul; 21(1):475. PubMed ID: 37461061
[TBL] [Abstract][Full Text] [Related]
31. MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing.
Bugg D; Bailey LRJ; Bretherton RC; Beach KE; Reichardt IM; Robeson KZ; Reese AC; Gunaje J; Flint G; DeForest CA; Stempien-Otero A; Davis J
Cell Stem Cell; 2022 Mar; 29(3):419-433.e10. PubMed ID: 35176223
[TBL] [Abstract][Full Text] [Related]
32. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.
Strutz F; Zeisberg M; Hemmerlein B; Sattler B; Hummel K; Becker V; Müller GA
Kidney Int; 2000 Apr; 57(4):1521-38. PubMed ID: 10760088
[TBL] [Abstract][Full Text] [Related]
33. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.
He J; Xu Y; Koya D; Kanasaki K
Clin Exp Nephrol; 2013 Aug; 17(4):488-97. PubMed ID: 23430391
[TBL] [Abstract][Full Text] [Related]
34. Janus-Faced: Molecular Mechanisms and Versatile Nature of Renal Fibrosis.
Arai H; Yanagita M
Kidney360; 2020 Jul; 1(7):697-704. PubMed ID: 35372942
[TBL] [Abstract][Full Text] [Related]
35. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
36. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.
Dolivo DM; Larson SA; Dominko T
Cytokine Growth Factor Rev; 2017 Dec; 38():49-58. PubMed ID: 28967471
[TBL] [Abstract][Full Text] [Related]
38. Physiology of the Renal Interstitium.
Zeisberg M; Kalluri R
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1831-40. PubMed ID: 25813241
[TBL] [Abstract][Full Text] [Related]
39. WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease.
Cohen C; Mhaidly R; Croizer H; Kieffer Y; Leclere R; Vincent-Salomon A; Robley C; Anglicheau D; Rabant M; Sannier A; Timsit MO; Eddy S; Kretzler M; Ju W; Mechta-Grigoriou F
Nat Commun; 2024 Jan; 15(1):743. PubMed ID: 38272907
[TBL] [Abstract][Full Text] [Related]
40. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
Front Immunol; 2022; 13():978262. PubMed ID: 36159833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
